Test Bank for Rau's Respiratory Care Pharmacology (Evolve), 11th Edition by Douglas S. Gardenhire | Updated 2025/2026 | 100% Verified Q&A

TEST BANK FOR RAUS RESPIRATORY CARE PHARMACOLOGY
11th EDITION BY GARDENHIRE/ALL CHAPTERS S 1-23

,CH 01: Introduction to Respiratory Care Pharmacology
Gardenhire: Rau’s Respiratory Care Pharmacology, 11th Edition


MULTIPLE RESPONSE

1. The listing of a drug and the amount of drug are found in which part of a prescription?
a. Superscription
b. Inscription
c. Subscription
d. Transcription (signature)
PRECISE ANSWER:-B
Reasoning :->>>The superscription directs the registered pharmacist to take the drug listed and preparethe
drug; the inscription lists the name and quantity of the drug being prescribed; the subscriptionprovides
directions to the registered pharmacist for preparing the drug; and the transcription, or signature, is the
information the registered pharmacist writes on the label as instructions to the patient.

REFERENCE: p. 7

2. If generic substitution is permitted on a prescription:
a. drug from only one manufacturer must be given.
b. drug formulation may be changed by the registered pharmacist.
c. any manufactured brand of the drug listed may be given.
d. drug strength may be changed by the registered pharmacist.
PRECISE ANSWER:-C
Reasoning :->>>A generic substitution allows any brand of a drug to be given, but the registered pharmacist
may not change a drug formulation without specific permission from the prescribing physician. A physician
can indicate to the registered pharmacist that generic substitution is permitted in the filling of the prescription.
In such a case, the registered pharmacist may provide any manufacturer’s version of the prescribed drug, rather
than a specific brand. However, the registered pharmacist may not change thestrength of a drug without
specific permission from the prescribing physician.

REFERENCE: p. 8

3. The study of drug, including their origin, properties, and interactions with living organisms, is known as
a. pharmacogenetics.
b. pharmacology.
c. therapeutics.
d. toxicology.
PRECISE ANSWER:-B
Reasoning:->>>Pharmacogenetics is the study of the interrelationship of genetic differences and drug effects.
Pharmacology is the study of drug (chemicals), including their origin, properties, and interactionswith living
organisms.
Therapeutics is the art of treating illness with drug. Toxicology is the study of toxic substances and their
pharmacologic actions, including antidotes and poison control.

REFERENCE: p. 3

4. The brand name given to a drug by a particular manufacturer is known as the drug’s
a. chemical name.
b. generic name. c.official name. d.trade name.
PRECISE ANSWER:-D
Reasoning:->>>The chemical name indicates the drug’s chemical structure. The generic name is assignedby the
United States

,Adopted MName MCouncil Mand Mis Musually Mbased Mloosely Mon Mthe Mdrug’s Mchemical Mstructure. MThe Mofficial
Mname M isMthe


name Mgiven Mto Mthe Mgeneric Mname Monce Ma Mdrug Mbecomes Mfully Mapproved Mfor Mgeneral Muse Mand Mis
Madmitted Mto Mthe MUnited MStates MPharmacopeia–National MFormulary. MThe Mtrade Mname Mis Mthe Mbrand, Mor

Mproprietary, Mname Mgiven Mby Ma Mparticular M manufacturer. MFor Mexample, Mthe Mgeneric M drug Malbuterol Mis

Mcurrently Mmarketed Mby MSchering-MPlough Mas MProventil
® Mand Mby MGlaxoSmithKline Mas MVentolin®.


REFERENCE: M p. M5

5. To Mfind Mofficial Minformation Mabout Mdrug M(according Mto Mthe MFDA), M you Mneed Mto Mgo Mto Mthe
a. Physician’s MDesk MReferenceerence M(PDR).
b. Basic M& MClinical MPharmacology.
c. United MStates MPharmacopeia–National MFormulary M(USP-NF).
d. Goodman M& MGilman’s MThe MPharmacological MBasis Mof MTherapeutics.
PRECISE MANSWER:-C
Reasoning:->>>Because Mthe MPDR Mis Mprepared Mby Mdrug Mmanufacturers Mthemselves, Mit Mmay Mbe Mlacking
Min Mobjectivity. MBasic M& MClinical MPharmacology Mcovers Monly Mgeneral Mpharmacologic Mprinciples Mand

Mdrug Mclasses. MGoodman M& MGilman’s MThe MPharmacological MBasis Mof MTherapeutics Mcovers Monly Mgeneral

MpharmacologicMprinciples Mand Mdrug Mclasses. MThe MUSP-NF Mis Ma Mbook Mof Mstandards Mcontaining

Minformation Mabout Mdrugs, Mdietary Msupplements, Mand Mmedical Mdevices. MThe MU.S. MFood Mand MDrug

MAdministration M(FDA)Mconsiders Mthis Mbook Mthe Mofficial Mstandard Mfor M drug Mmarketed Min Mthe MUnited

MStates.



REFERENCE: M p. M5



6. Drug Mmay Mbe Mobtained Mfrom Mwhich Mof Mthe Mfollowing Msources?
a. Plants
b. Animals
c. Minerals
d. Plants, Manimals, Mand Mminerals
PRECISE MANSWER:-D
Reasoning:->>>Drug Mmay Mbe Mobtained Mfrom Mplants M(e.g., Mdigitalis), Manimals M(e.g., Minsulin), Mand Mminerals
M(e.g., Mmagnesium Msulfate).



REFERENCE: M p. M5

7. The Mbranch Mof Mthe MU.S. Mgovernment Mresponsible Mfor Mthe Mprocess Mof Mapproving Mdrug Mfor Mclinical Muse Mis
the
M

a. USAN MCouncil.
b. FDA.
c. USP-NF.
d. PDR.
PRECISE MANSWER:-B
Reasoning:->>>The MUnited MStates MAdopted MName M(USAN) MCouncil Mis Mresponsible Mfor Massigning Ma
Mgeneric Mname Mto Ma Mchemical Mthat Mappears Mto Mhave Mtherapeutic Muse. MThe MU.S. MFood Mand MDrug

MAdministration M(FDA) Mis Mresponsible Mfor Mthe Mprocess Mof Mapproving Mdrug Mfor Mclinical Muse. MThe Mprocess

Mby Mwhich Ma Mchemical MmovesMfrom Mthe Mstatus Mof Ma Mpromising Mpotential Mdrug Mto Mone Mfully Mapproved Mby

Mthe MFDA Mfor Mgeneral Mclinical Muse M is,Mon Maverage, Mlong, Mcostly, Mand Mcomplex. MCost Mestimates Mvary, Mbut

Min Mthe M1980s Mit Mtook M an Maverage Mof M13 Mto M15 MyearsMfrom Mchemical Msynthesis Mto Mmarketing Mapproval

Mby Mthe MFDA, Mwith Ma Mcost Mof M$350 Mmillion Min Mthe MUnited MStates.

The MUSP-NF Mis Ma Mbook
of Mstandards Mfor Mdrugs, Mdietary Msupplements, Mand Mmedical Mdevices. MThe MPDR Mis Ma Msource Mof Mdrug
Minformation Mprepared Mby Mdrug M manufacturers.

, REFERENCE: M p. M4